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Optical control of GPR40 signalling in pancreatic β-cells 
James Allen Frank,a Dmytro A. Yushchenko,b,c Nicholas H.F. Fine,d,e Margherita Duca,a,f Mevlut 
Citir,b Johannes Broichhagen,a,g David J. Hodson,*d,e Carsten Schultz,*b,h, Dirk Trauner*a,i 
Fatty acids activate GPR40 and K+ channels to modulateβ-cell function. Herein, we describe the design and synthesis of 
FAAzo-10, a light-controllable GPR40 agonist based on Gw-9508. FAAzo-10 is a potent GPR40 agonist in the trans-
configuration and can be inactivated on isomerization to cis with UV-A light. Irradiation with blue light reverses this effect, 
allowing FAAzo-10 activity to be cycled ON and OFF with a high degree of spatiotemporal precision. In dissociated primary 
mouse β-cells, FAAzo-10 also inactivates voltage-activated and ATP-sensitive K+ channels, and allows us to control glucose-
stimulated Ca2+ oscillations in whole islets with light. As such, FAAzo-10 is a useful tool to study the complex effects, with 
high specificity, which FA-derivatives such as Gw-9508 exert at multiple targets in mouse β-cells. 
Introduction 
Although minimalistic in structure and often viewed as 
subunits of more complex lipids or simply an energy source, 
fatty acids can have profound effects on cell signalling.
1–4
 Free 
fatty acids most often consist of a long, unbranched carbon 
chain attached to a carboxyl headgroup, which is largely 
deprotonated and thus negatively charged at physiological 
pH.
5
 They are amphiphilic molecules with diverse structures 
that vary in the chain length and the level of unsaturation. A 
number of transmembrane signalling proteins, including 
G protein-coupled receptors (GPCRs) such as the GPR40,
6
 are 
stimulated by free fatty acids,
7
 resulting in a rise in the 
intracellular Ca
2+
 concentration ([Ca
2+
]i) in insulin-secreting 
pancreatic β-cells through activation of phospholipase C.
8–10
 
Given the role of GPR40 in glucose homeostasis, synthetic 
agonists for these receptors such as Gw-9508
11,12
 and TAK-
875
13,14
 have received significant attention as potential 
treatments for type 2 diabetes mellitus.
15,16
 However, a phase 
III clinical trial for TAK-875 was recently terminated due to off-
target effects and toxicity concerns.
17,18
 
 Glucose-stimulated insulin secretion (GSIS) relies on 
transport of glucose into the β-cell, followed by its metabolism 
to ATP. The resulting increase in the ATP/ADP ratio leads to 
closure of ATP-sensitive K
+
 channels (KATP) and subsequent 
membrane depolarization. This causes the opening of voltage 
activated L-type Ca
2+
 channels (Cav) and an increase in [Ca
2+
]i, 
driving exocytosis of insulin secretory granules
19
. Subsequent 
activation of delayed rectifier voltage-activated K
+ 
(Kv) 
channels leads to repolarization of the membrane, reduced 
Ca
2+ 
entry through Cav channels and termination of insulin 
secretion (Fig. 1).
20
 This is complemented by the action of 
other messengers, including those stemming from GPCRs (so-
called “amplifying” signals). Notably, the amplifying effects of 
GPR40 activation on insulin secretion remain elusive due to 
Fig. 1 Glucose-stimulated insulin secretion (GSIS) from pancreatic β-cells. Upon 
uptake into the pancreatic β-cell, glucose is metabolized into ATP. The rising 
ATP/ADP ratio inhibits KATP which causes membrane depolarization and the 
opening of Cav. channels. The resulting increased [Ca
2+]i triggers the fusion of 
secretory granules and the release of insulin. Kv channels work to repolarize the 
cell, generating oscillations in [Ca2+]i. GPR40 stimulation also leads to increased 
[Ca2+]i, further potentiating GSIS. 
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conflicting results in different experimental conditions,
12,21
 
which could be attributed to effects of FAs at different targets. 
For example, fatty acids are known to directly affect various K
+
 
channels that are involved in modulation of the [Ca
2+
]i 
oscillation frequency,
1,22,23
 demonstrating their complex 
pharmacology and vital role in β-cell signalling. Therefore, a 
tool that could enable precise control over GPR40 signalling 
may be useful to better understand the effects of fatty acids, 
as well as specific agonists, on β- and other cell functions. This 
could lead to the development of novel therapeutics by 
delineating the receptor conformations required for biased 
signalling.
18,24
 
Previous studies in our laboratories have focused on the 
development of photoswitchable sulfonylureas and incretins, 
with which we could place pancreatic β-cell function under the 
precise spatiotemporal control of light.25–29 We also showed 
that photoswitchable diacylglycerols30–32 affect β-cell [Ca2+]i 
and insulin secretion. These diacylglycerols were constructed 
from a photoswitchable fatty acid (FAAzo) chain, however the 
pharmacology of these FAAzos alone remains largely 
unexplored. Given the sensitivity of GPR40 to unsaturated, and 
sometimes aryl-containing free fatty acid-like molecules, we 
hypothesized that the FAAzos themselves could enable optical 
control of this GPCR. Herein, we describe a novel approach 
towards the optical control of fatty acid/GPR40 signalling in β-
cells. 
Results and discussion 
Although GPR40 is activated by long-chain fatty acids such as 
arachidonic or linoleic acid,
10
 various aryl-containing carboxylic 
acids such as Gw-9508 are known to produce a similar effect 
(Fig.2a).
3
 We recognized that the benzyl-aniline moiety of 
Gw-9508 could be easily substituted by a phenyl diazene, and 
would afford a photoswitchable ligand with little disturbance 
to the overall size and structure of the drug. Therefore, we 
synthesized the azologue33 of Gw-9508, FAAzo-10, using the 
Mills reaction after nitroso formation in two steps and 45% 
overall yield (Fig. 2b). Similar to the other members of the 
FAAzo family,30 FAAzo-10 behaved as a regular azobenzene 
and could be isomerized between its thermally stable trans-
Fig.2 Design and synthesis of photoswitchable GPR40 agonists. (a) The chemical 
structures of Gw-9508, AA and FAAzo-4. (b) Chemical synthesis of FAAzo-10, a 
photoswitchable derivative of Gw-9508. (c) The UV-Vis spectra of FAAzo-10 in 
its dark-adapted (black), UV-adapted (gray) and blue-adapted (blue) states 
(20µM in PBS). 
Fig. 3 FAAzos enable optical control of GPR40 in HeLa cells expressing GPR40, C1-GFP. [Ca2+]i levels were recorded using the genetically encoded [Ca
2+]i sensor R-GECO. (a) 
Spontaneous oscillations of [Ca2+]i were observed before addition of any compound. (b) Gw-9508 (200 nM) caused an increase in [Ca
2+]i that was not affected by 375 nm irradiation. 
HIS (10 nM) application caused an increase in [Ca2+]i (n = 179 cells from two experiments). (c,d) trans-FAAzo-10 (200 nM) increased [Ca
2+]i, and isomerization to cis-FAAzo-10 with 
375 nm light reversed this effect. Displayed as (c) individual [Ca2+]i traces from representative cells and (d) the average [Ca
2+]I  for many cells (n = 157 cells from two experiments). (e) 
In cells not expressing GPR40, FAAzo-10 (200 nM) did not affect [Ca2+]i. (f) At 200 nM, FAAzo-4 (n = 211 cells from two experiments) did not affect [Ca
2+]i  when compared to FAAzo-
10 (n = 153 cells from two experiments).(g) The fluorescent diacylglycerol sensor C1-GFP translocated to the plasma membrane alongside the increase in [Ca2+]i  when stimulated by 
trans-FAAzo-10 (20 µM, n = 10 cells from one representative experiment). Translocation (green) is displayed as the plasma membrane to cytoplasm (PM/CP) C1-GFP fluorescence 
intensity ratio. (h) Quantification of cell entry: fluorescence quenching of coumaryl-AA-loaded (100 nM) HeLa cells after application (100 nM, 2 experiments each) of FAAzo-4 (n = 29 
cells, orange), FAAzo-10 (n = 23 cells, green) and PhoDAG-1 (n = 39 cells, grey), respectively. Error bars were calculated as ± s.e.m. 
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form to the cis-form with UV-A light (Fig. 2c). The process 
could be reversed by irradiation with blue light, and 
photoswitching could be repeated over many cycles. 
 We then characterized the effects of FAAzo-10 on GPR40 in 
HeLa cells using confocal fluorescence microscopy and the 
genetically encoded fluorescent [Ca
2+
]i reporter R-GECO.
34
 
When transiently transfected with GPR40, a portion of cells 
displayed spontaneous [Ca
2+
]i oscillations without the addition 
of any external stimuli (Fig.3a, Fig. S1a). Gw-9508 induced a 
GPR40-dependent increase in the rate and intensity of [Ca
2+
]i 
oscillations, that was not affected by UV-A-irradiation (Fig.3b, 
Fig. S1b). In cells without GPR40, no response was observed 
(Fig.S1c,d). Complementary to this result, the application of 
trans-FAAzo-10 (200 nM) stimulated a significant increase in 
[Ca2+]i in HeLa cells expressing GPR40 (Fig. 3c,d). On 
isomerization to cis with 375 nm irradiation, a sharp decrease 
in the [Ca2+]i was observed. The effect was reversed and [Ca
2+]I 
increased on termination of the irradiation. In cells lacking 
GPR40, FAAzo-10 did not affect [Ca2+]I (Fig. 3e, Fig. S1e). We 
also evaluated the effect of FAAzo-4, which possesses a similar 
structure to FAAzo-10, but was not active at this low 
concentration (Fig. 3f). Histamine35 (HIS, 10 µM) was used as a 
positive control and triggered a large increase in [Ca2+]i, 
independent of GPR40 expression (Fig. 3, Fig. S1).  
To investigate the downstream effects of GPR40 activation, 
we expressed the fluorescent diacylglycerol reporter C1-GFP, 
which translocates to the plasma membrane in response to 
increased diacylglycerol levels following PLC activation.36 Gw-
9508 (200 nM) triggered C1-GFP translocation towards the 
plasma membrane, indicating activation of the GPCR (Fig. 
S1f,g). On application of trans-FAAzo-10 (20 μM), we observed 
a similar effect on C1-GFP translocation. This could be reversed 
following isomerization to cis-FAAzo-10 with 375 nm 
irradiation, and translocation could be repeated over many 
cycles (Fig. 3g). These results demonstrate that oscillations in 
GPR40 activity and its downstream effectors (i.e. PLC, [Ca2+]i 
and diacylglycerols) can be modulated with good temporal 
control. 
 Surprisingly, the effects induced by the FAAzos in HeLa cells 
did not diminish over time (Fig. 3), unlike those induced by the 
photoswitchable diacylglycerol PhoDAG-1, which decreased in 
magnitude over multiple UV-A pulses of the same length.31 To 
control for differences in cell loading, we applied the 
coumarinyl-ester of AA (cg-AA) to the HeLa cells.6 This 
fluorescent fatty acid-derivative localizes predominantly at the 
inner cellular membranes.31 By monitoring the quenching of 
coumarin fluorescence by the azobenzene of FAAzos, we 
demonstrated that this observed variance in activity was not 
due to variable FAAzo uptake by cells. Application of both 
FAAzos caused a rapid and large (>60%) decrease in coumarin 
fluorescence (Fig. 3h), especially when compared to the 
quenching effect of PhoDAG-1 (<20%), which is known to 
remain trapped on the outer plasma membrane.31 A cellular 
lipid analysis by thin layer chromatography (TLC) confirmed 
only minor FAAzo metabolism in cells incubated with FAAzo-4 
and FAAzo-10 (100 µM) for up to 1 h (Fig. S2). Together, these 
results demonstrate that the FAAzos are quickly taken up into 
cells, and only minimally metabolized over the timeframe of a 
typical imaging experiment. 
A major advantage of FAAzo-10 when compared to 
conventional agonists is the ability to modulate GPR40 activity 
with increased spatial precision. By illuminating only cells of 
interest, we were able to selectively control GPR40 activity 
without affecting signalling in neighbouring unilluminated cells 
(Fig. 4). This allows GPR40 activity to be controlled in a 
spatially defined manner in large patches of cells or complex 
tissues.  
To evaluate the effects of FAAzo-10 on K
+
 channels, we 
used whole-cell electrophysiology in dissociated mouse β-cells, 
which express both Kv and KATP channels.
37,38
 Kv channel 
conductance is a major determinant of the [Ca
2+
]i oscillation 
frequency.
20
 Like AA
31
 and Gw-9508 (Fig. 5a), trans-FAAzo-10 
reduced Kv channel conductance in the dark or under blue 
irradiation (Fig. 5b). On isomerization to cis-FAAzo-10, Kv 
channel activity was restored to a level comparable with the 
vehicle controls (Fig. 5a). FAAzo-10 could be switched ON and 
OFF repeatedly, effectively allowing us to quickly mimic the 
wash-in and wash-out of Gw-9508 using only a UV-A/blue 
irradiation (Fig. 5c). Furthermore, we could also fine-tune the 
effect of FAAzo-10 with greater precision by scanning through 
different irradiation wavelengths. The Kv conductance could be 
precisely controlled by gradually increasing the blocking effect 
of FAAzo-10 when scanning from UV-A to blue wavelengths. 
This was demonstrated by applying voltage ramps under 350-
450 nm irradiation (Fig. 5d,e). 
Gw-9508 has also been shown to potentiate KATP channels 
in mouse β-cells.
11
 We measured the whole-cell KATP current 
without extracellular glucose. IV-curves were measured 
between −110 and −50 mV to exclude any effect of the Kv 
Fig. 4 Spatial control of GPR40 signalling with FAAzo-10. (a) Confocal images of 
HeLa cells expressing GPR40 and R-GECO before and after treatment with FAAzo-
10 (200 nM) and illumination with 375 nm light. The green rectangle indicates the 
area of illumination. After addition of FAAzo-10, all transfected cells showed 
increased [Ca
2+
]i. Following illumination, only cells within the green rectangle 
showed a sharp decrease in [Ca
2+
]i levels, which recovered after termination of 
illumination. Scale bar = 100 μm.(b) Normalized [Ca
2+
]i in illuminated cells (within 
the green rectangular in (a)) in blue (n = 52) and those in unilluminated cells 
(outside the green rectangular) in black (n = 82). Time points 1-4 correspond to 
the respective time frames in (a). Error bars were calculated as ± s.e.m. 
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channels. After dialysis of the cytoplasm with intracellular 
buffer to reduce the ATP/ADP ratio, the KATP current increased 
to a steady state (Fig. 6a, Fig. S3a). In line with previous 
reports, Gw-9508 increased the KATP conductance further 
(Fig. 6a,c). 
 Interestingly, trans-FAAzo-10 behaved differently, and 
reduced the KATP conductance, while isomerization to 
cis-FAAzo-10 reversed the effect (Fig. 6b). Similar to the 
effects observed on the Kv channels, FAAzo-10 activity at KATP 
could be fine-tuned by altering the irradiation wavelength 
(Fig. 6d). Under blue irradiation, the KATP current was reduced, 
while the blockade was reversed towards UV-A wavelengths. 
In control experiments, application of the sulfonylurea 
tolbutamide reduced the KATP current significantly (Fig. 6e, Fig 
S3a), and neither UV-A no blue irradiation alone affected the 
KATP conductance (Fig. 6e, Fig. S3). 
 Finally, we evaluated our photoswitchable ligands for their 
effects on intact pancreatic islets using confocal fluorescence 
imaging. We employed the fluorescent small-molecule [Ca2+]I 
indicator Fluo-8 to monitor [Ca2+]I oscillations stimulated by a 
high glucose concentration (11 mM). Similar to the application 
of Gw-9508 (Fig.7a,b), application of trans-FAAzo-10 (20 µM) 
caused a marked increase in the [Ca2+]i oscillation frequency 
(Fig. 7c,d). In line with the effects that would be expected from 
our results on GPR40, Kv, and KATP, isomerization to 
cis-FAAzo-10 with 365 nm irradiation reversed this effect 
entirely (Fig. 7e). Lower concentrations of FAAzo-10 (2.5 µM) 
did not affect oscillation frequency in either configuration 
(Fig. 7f). To exclude imaging artifacts, in particular 
fluorescence quenching, the cells were treated with a methyl 
ester FAAzo-derivative, FAAzo-5(OMe), which possesses an 
azobenzene photoswitch with similar spectral characteristics 
to FAAzo-10.30 FAAzo-5(OMe) produced a small increase in the 
[Ca2+]I oscillation frequency in either configuration (Fig. S4a-c), 
as methyl esterification of the acid group abolished cis-activity. 
Although FAAzo-10 effectively increased [Ca2+]I oscillations, we 
did not observe a significant increase in insulin secretion in 
either trans or cis at both low (3 mM) and high (11 mM) glucose 
concentrations (Fig. 7g). Similarly, benchmark Gw-9508 did not 
stimulate GSIS at 3 mM or 11 mM glucose (Fig. 7g). An effect of 
BSA on Gw-9508 and/or FAAzo-10 potency was unlikely, since 
assays with low (3 mM) glucose concentration were performed 
in the absence of BSA. Experiments were also repeated at high 
(17 mM) glucose, but without BSA, showing a similar lack of 
stimulation with Gw-9508 or FAAzo-10 (Fig. S4d). Neither 
FAAzo-10 nor Gw-9508 were able to suppress tolbutamide-
stimulated insulin secretion, further supporting an effect on 
KATP channel conductance.
11 UV-A irradiation alone did not 
affect oscillatory behavior or insulin secretion levels, as 
expected from previous studies25,31 (Fig. S4e). 
Fig. 5 Optical control of β-cell Kv channel activity. The 
whole-cell Kv channel current in dissociated wt mouse β-
cells was measured using electrophysiology. (a) An IV-
plot showed that Gw-9508 (50 µM)(n = 8 cells from 2 
animals) reduced the Kv conductance when compared to 
a vehicle control (n = 6 cells from 3 animals). (b) Under 
blue light, trans-FAAzo-10 (20 µM) reduced the whole-
cell Kv current. Isomerization to cis-FAAzo-10 with UV-A 
light reversed this effect(n = 7 cells from 3 animals). 
(c) Similar to the wash-in and wash-out of Gw-9508, 
FAAzo-10 could be activated and inactivated over several 
cycles using irradiation. Shown are IV-steps from −70 to 
+80 mV from representative cells. (d,e) An action 
spectrum between 350-450 nm showed that Kv activity 
could be fine-tuned by changing the irradiation 
wavelength. Displayed as (d)overlaid sequential voltage 
ramps (−70 to +80 mV) from a representative cell and (e) 
the normalized current (to I350nm) under each wavelength 
(n = 3 cells from 2 animals). Error bars were calculated as 
±s.e.m. 
Fig. 6 Optical control of β-cell KATP channels. The whole-cell KATP current from 
dissociated mouse β-cells was measured between −110 to −50 mV. (a-c) After 
dialysis of the cytoplasm with the pipette solution, the KATP current developed to a 
steady state (black = before, n = 21; green = after, n = 20 cells from 2 animals). 
Application of Gw-9508 (20 µM, red, n = 9 cells from 2 animals) increased KATP 
conductance. In contrast, the application of trans-FAAzo-10 (20 µM, blue) 
decreased the KATP current, while isomerization to cis-FAAzo-10 (gray) reversed this 
effect (n = 7 cells from 2 animals). Data is displayed as (a,b) the full IV relationship 
between −110 to −50 mV and (c) the % KATP current (at −110 mV) for multiple cells, 
normalized to the KATP open (green) state. (d) In the presence of FAAzo-10, an 
action spectrum between 350-450 nm revealed that KATP was inhibited the most 
under blue irradiation. Irradiation with UV-A light prevented FAAzo-10 from 
blocking the KATP current. Displayed as the normalized current (to I350nm) under each 
wavelength (n = 3 cells from one animal). (e) UV-A or blue irradiation did not affect 
the KATP current, and tolbutamide (40 µM) significantly reduced the magnitude of 
the KATP current (∆I from −110 to −50 mV, n = 3 cells from one animal).  ns = P>0.05, 
*P<0.05, **P<0.01. Error bars were calculated as ± s.e.m. 
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Conclusions 
In summary, we have demonstrated that FAAzo-10 is a potent 
photoswitchable agonist of GPR40, and reversibly inactivates 
K
+
 channels in dissociated mouse β-cells. Although our 
previous studies using the FAAzos conjugated to different 
headgroups afforded cis-active compounds,
30,31
 we found the 
opposite in this case. FAAzo-10 was more active in the trans-
form at all targets, and can reversibly stimulate [Ca
2+
]i 
oscillations in pancreatic β-cells using light. Interestingly, 
stimulation of [Ca
2+
]i oscillations with FAAzo-10 did not 
translate to increased insulin secretion in primary mouse islets, 
in line with the effects of benchmark Gw-9508. This suggests 
that oscillations by themselves are potentially not a sufficient 
signal for effective granule fusion, and that an additional factor 
was not triggered under these conditions. Of note, previous 
studies using Gw-9508 have afforded either stimulatory, 
inhibitory or no effect on insulin secretion,
11,21,39
 with two 
conflicting reports in mouse islets.
12,40
 As previously alluded to 
using the PhoDAGs,
31
 the variation of the effects induced by 
Gw-9508 application may stem from different protein 
expression levels or membrane area between immortalized 
and primary cells, or conversely off-target effects on GPR120, 
which shares some homology with GPR40. Similarly, 
differential effects caused by plasma membrane vs. 
intracellular fatty acid-signalling, as was observed using caged 
AA-derivatives, may contribute to this effect.
6
 By contrast, long 
chain fatty acids such as linoleic and palmitic acid have been 
consistently shown to potently stimulate insulin secretion, and 
this can be abrogated by GPR40 knockdown/silencing.
18
 Our 
studies thus reinforce the notion that signals in addition to 
GPR40 activation may be required for fatty-acid-stimulated 
insulin release, highlighting the complexity of fatty acid 
signalling in the β-cell, and underscoring the importance of 
FAAzo-10 for studying the intricate relationship between 
[Ca2+]i oscillations and insulin secretion. More broadly, FAAzo-
10 opens up the possibility to precisely interrogate the 
contribution of GPR40 signalling in different body 
compartments (e.g. brain and liver) to glucose homeostasis.  
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